Combination of Peptide YY3–36with GLP-17–36 amideCauses an Increase in First-Phase Insulin Secretion after IV Glucose | Zendy

Tricia Tan | Zendy; Victoria Salem | Zendy; R. Troke | Zendy; Ali Alsafi | Zendy; Benjamin Field | Zendy; Akila De Silva | Zendy; Shivani Misra | Zendy; Kevin Baynes | Zendy; Mandy Donaldson | Zendy; James Minnion | Zendy; Mohammad A. Ghatei | Zendy; Ian F. Godsland | Zendy; Stephen R. Bloom | Zendy

Open Access

Combination of Peptide YY_3–36with GLP-1_{7–36 amide}Causes an Increase in First-Phase Insulin Secretion after IV Glucose

Author(s) -

Tricia Tan,

Victoria Salem,

R. Troke,

Ali Alsafi,

Benjamin Field,

Akila De Silva,

Shivani Misra,

Kevin Baynes,

Mandy Donaldson,

James Minnion,

Mohammad A. Ghatei,

Ian F. Godsland,

Stephen R. Bloom

Publication year - 2014

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2014-2143

Subject(s) - peptide yy , endocrinology , medicine , insulin , glucose homeostasis , glucagon like peptide 1 , pancreatic hormone , insulin resistance , chemistry , homeostasis , hormone , diabetes mellitus , amide , type 2 diabetes , neuropeptide , biochemistry , receptor , neuropeptide y receptor

The combination of peptide YY (PYY) and glucagon-like peptide-1 (GLP-1) has been proposed as a potential treatment for diabetes and obesity. However, the combined effects of these hormones, PYY(3-36) and GLP-1(7-36 amide), on glucose homeostasis are unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research